Abstract
Major artery disease and small vessel disease constitute the main causes of ischemic stroke. However, ischemic stroke can also occur as a complication of systemic diseases, some of which, such as systemic vasculitides, have been discussed elsewhere in this book. This chapter describes several rarer systemic causes of ischemic stroke and the role of clinical neuroradiology in the differential diagnosis and monitoring of complications. The effects of hematological conditions like antiphospholipid syndrome, thrombotic thrombocytopenic purpura, and sickle cell disease on the brain will be described. MELAS is one the most important hereditary syndromes that causes ischemic-like neurological deficits. Sneddon’s syndrome is characterized by a combination of skin disease and cerebral lesion. In these rare diseases, magnetic resonance imaging (MRI) is the preferred radiological technique for identification of subtle abnormalities and to narrow the differential diagnosis.
This publication is endorsed by: European Society of Neuroradiology (www.esnr.org).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- ACA:
-
Anterior cerebral artery
- ADAMTS-13:
-
A disintegrin and metalloproteinase with thrombospondin type 1 motif, 13
- APS:
-
Antiphospholipid syndrome
- ASL:
-
Arterial spin labelling
- CSF:
-
Cerebral spinal fluid
- CT:
-
Computed tomography
- DNA:
-
Deoxyribonucleic acid
- DWI:
-
Diffusion weighted imaging
- FLAIR:
-
Fluid attenuated inversion recovery
- HbSS:
-
Homozygous hemoglobin S
- HIV:
-
Human immunodeficiency virus
- MCA:
-
Middle cerebral artery
- MELAS:
-
Mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes
- MM:
-
Multiple myeloma
- MRA:
-
Magnetic resonance angiography
- MRI:
-
Magnetic resonance imaging
- PCA:
-
Posterior cerebral artery
- PRES:
-
Posterior reversible encephalopathy syndrome
- SCD:
-
Sickle cell disease
- SLE:
-
Systemic lupus erythematosus
- SS:
-
Sneddon’s syndrome
- SWI:
-
Susceptibility weighted imaging
- T1w:
-
T1 weighted
- T2w:
-
T2 weighted
- TIA:
-
Transient ischemic attack
- TCD:
-
Transcranial Doppler
- TOF-MRA:
-
Time of flight magnetic resonance angiography
- TTP:
-
Thrombotic thrombocytopenic purpura
- VZV:
-
Varizella zoster virus
- WM:
-
Waldenström’s macroglobulinemia
- WML:
-
White matter lesions
References
Burrus TM, Wijdicks EFM, Rabinstein AA. Brain lesions are most often reversible in acute thrombotic thrombocytopenic purpura. Neurology. 2009;73(1):66–70.
DeBaun MR, Kirkham FJ. Central nervous system complications and management in sickle cell disease. Blood. 2016;127(7):829–38.
Ford AL, Ragan DK, Fellah S, Binkley MM, Fields ME, Guilliams KP, An H, Jordan LC, McKinstry RC, Lee J-M, DeBaun MR. Silent infarcts in sickle cell disease occur in the border zone region and are associated with low cerebral blood flow. Blood. 2018;132(16):1714–23.
Miao X, Choi S, Tamrazi B, Chai Y, Vu C, Coates TD, Wood JC. Increased brain iron deposition in patients with sickle cell disease: an MRI quantitative susceptibility mapping study. Blood. 2018;132(15):1618–21.
Ong E, Barraco F, Nighoghossian N, Praire A, Desestret V, Derex L, Vighetto A, Biotti D. Cerebrovascular events as presenting manifestations of Myeloproliferative Neoplasm. Rev Neurol. 2016;172(11):703–8.
Schatz J, Brown RT, Pascual JM, Hsu L, DeBaun MR. Poor school and cognitive functioning with silent cerebral infarcts and sickle cell disease. Neurology. 2001;56(8):1109–11.
Suggested Reading Sneddon’s Syndrome
Boesch SM, Plörer AL, Auer AJ, Poewe W, Aichner FT, Felber SR, et al. The natural course of Sneddon syndrome: clinical and magnetic resonance imaging findings in a prospective six year observation study. J Neurol Neurosurg Psychiatry. 2003;74(4):542–4.
Bottin L, Francès C, de Zuttere D, Boëlle PY, Muresan IP, Alamowitch S. Strokes in Sneddon syndrome without antiphospholipid antibodies. Ann Neurol. 2015;77(5):817–29.
Francès C, Papo T, Wechsler B, Laporte JL, Biousse V, Piette JC. Sneddon syndrome with or without antiphospholipid antibodies. A comparative study in 46 patients. Medicine (Baltimore). 1999;78(4):209–19.
Hilton DA, Footitt D. Neuropathological findings in Sneddon’s syndrome. Neurology. 2003;60(7):1181–2.
Stockhammer G, Felber SR, Zelger B, Sepp N, Birbamer GG, Fritsch PO, et al. Sneddon’s syndrome: diagnosis by skin biopsy and MRI in 17 patients. Stroke. 1993;24(5):685–90.
Suggested Reading MELAS
Haas R, Dietrich R. Neuroimaging of mitochondrial disorders. Mitochondrion. 2004;4(5–6):471–90.
Ito H, Mori K, Kagami S. Neuroimaging of stroke-like episodes in MELAS. Brain Dev. 2011;33(4):283–8.
Kim JH, Lim MK, Jeon TY, Rha JH, Eo H, Yoo SY, Shu CH. Diffusion and perfusion characteristics of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode) in thirteen patients. Korean J Radiol. 2011;12(1):15–24.
Sue CM, Crimmins DS, Soo YS, Pamphlett R, Presgrave CM, Kotsimbos N, Jean-Francois MJ, Byrne E, Morris JG. Neuroradiological features of six kindreds with MELAS tRNA(Leu) A2343G point mutation: implications for pathogenesis. J Neurol Neurosurg Psychiatry. 1998;65(2):233–40.
Tzoulis C, Bindoff LA. Serial diffusion imaging in a case of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes. Stroke. 2009;40(2):e15–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Svrckova, P., van der Lugt, A. (2019). Rarer Systemic Causes of Ischemic Stroke. In: Barkhof, F., Jäger, H., Thurnher, M., Rovira, À. (eds) Clinical Neuroradiology. Springer, Cham. https://doi.org/10.1007/978-3-319-68536-6_26
Download citation
DOI: https://doi.org/10.1007/978-3-319-68536-6_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-68535-9
Online ISBN: 978-3-319-68536-6
eBook Packages: MedicineReference Module Medicine